- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PCRX
Recent news which mentions PCRX
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
These small-cap stocks might make you the most money in 2023, based on two important data points
December 07, 2022
From MarketWatch
Pacira BioSciences's Return On Capital Employed Insights
November 23, 2022
Tickers
PCRX
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
From Benzinga
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
September 21, 2022
Tickers
PCRX
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
September 07, 2022
Tickers
PCRX
From Benzinga
10 Biggest Price Target Changes For Wednesday
June 15, 2022
From Benzinga
Pacira BioSciences Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
PCRX
From Benzinga
3 Small-Cap Medical Stocks With Big Momentum
April 27, 2022
From Motley Fool
28 Biggest Movers From Yesterday
April 12, 2022
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Pacira BioSciences, inc (PCRX) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
PCRX
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
FLXN Stock Is Winning Big Today Ahead of Merger With Pacira
October 11, 2021
From InvestorPlace
Pacira Beefs Up Non-Opioid Pain Management Via Flexion Acquisition
October 11, 2021
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.